While AZ is eyeing overseas expansion with its new investment, J&J has embarked on a reshoring drive with a pledge to invest ...

AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...

All this results in what Joe Daley, president of Addison Whitney, the global branding agency that named Ozempic and Wegovy, ...

February saw several changes on boards at biotechs, bringing a diverse wealth of experience to support these companies. Read ...

It’s time to shine a light on the next wave of drug discovery.

DCT approaches in Japan typically involve partnerships among multiple satellite hospitals. Three main models aim to boost ...

Alnylam has the FDA approval it sought for Amvuttra in a form of cardiomyopathy associated with rare disease ATTR amyloidosis ...

Johnson & Johnson's FcRn inhibitor nipocalimab has been awarded fast-track status by the FDA as a treatment for Sjögren's ...

The model employed by North Carolina’s regenerative medicine ecosystem can be adapted by other accelerators and organisations ...

It has already been speculated that AstraZeneca's termination of a plan to invest £450 million in a new vaccine manufacturing ...

The VER-01 therapy – a cannabis extract that includes the full range of cannabinoid compounds, including low levels of THC – ...

Under the terms of the deal, Sanofi will pay $600 million upfront to buy an affiliate of the California-based biotech, called ...